Concepedia

Angus M. MacLeod

AM

51

Publications

3.1K

Citations

30

H-Index

1988

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

United States Military Academy

Galapagos (Belgium)

Angus M. MacLeod is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1988–2016

51

Publications

51

An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

Gerard R. Dawson, Karen Maubach, Neil Collinson et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 240 citations

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

F.D. Tattersall, Wayne Rycroft, B. Francis et al. · Neuropharmacology · 1996 · 211 citations

, , +6

Novel quinuclidine-based ligands for the muscarinic cholinergic receptor

John Saunders, Stephen B. Freedman, Elizabeth A. Harley et al. · Journal of Medicinal Chemistry · 1990 · 157 citations

, , +17

Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT<sub>1D</sub> Receptor Ligands with Improved Pharmacokinetic Profiles

Monique B. van Niel, Ian Collins, Margaret S. Beer et al. · Journal of Medicinal Chemistry · 1999 · 157 citations · Full text

, , +15

Identification of a Novel, Selective GABA<sub>A</sub>α5 Receptor Inverse Agonist Which Enhances Cognition

Mark S. Chambers, John Atack, Howard B. Broughton et al. · Journal of Medicinal Chemistry · 2003 · 140 citations · Full text

, , +22

Rows per page

1–5 of 51